Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neurofibromatosis 1 3Warts 1Recurrence 1Port-Wine Stain 1Periodontitis 1Neurofibromatoses 1Lymphoma, Follicular 1Leukoplakia 1Laryngeal Neoplasms 1Hemangioma, Capillary 1Chronic Periodontitis 1Carcinoma 1

Interventions

Surveys and Questionnaires 2Imatinib Mesylate 2talimogene laherparepvec 1pirfenidone 1nilotinib 1mirdametinib 1diphenylcyclopropenone 1cabozantinib 1binimetinib 1Sunitinib 1Sirolimus 1Sevoflurane 1Propofol 1Percutaneous Collagen Induction 1Nitrous Oxide 1Lidocaine 1Lasers, Solid-State 1Lasers 1Glycopyrrolate 1Dexmedetomidine 1Blood Specimen Collection 1Aminolevulinic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neurofibromatoses × Lasers, Solid-State × Clear all
NCT06934928 2026-06-04

Assessing the Efficacy of Repeat, Monthly Treatments of Alexandrite Laser for NF1-associated Cutaneous Neurofibromas (cNFs)

Massachusetts General Hospital

Phase NA Suspended
10 enrolled
CNS

Neurofibromatosis 1, Neurofibromatoses

Data powered by HemOnc (CC BY 4.0) Colophon âš¡